Study · Non-randomized trial · 2025
4 resultsGe S, Liu Y, Li D, Han G, Niu K, Ju H, Zhou H, Liu R, Zhu Z, Liu N, Qu L
Experimental cell research8 Oct 2025Cited by 1 (Europe PMC)
The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)
Text rights: Publisher copyright. Results still quote short attributed sentences.
4 results from studies that gave the peptide. 2 results from people.
In humans, NMN supplementation increased NAD turnover.
In plain wordsIn humans, NMN increased NAD turnover.
n: not reported in source
Source sentences
We demonstrated that NMN supplementation increases NAD turnover coupled with a reduction in NAD-capped RNAs in both human and dog, revealing blood-derived NAD-RNAs as potential biomarkers sensitized to NMN exposure.
In humans, NMN supplementation reduced NAD-capped RNAs.
In plain wordsIn humans, NMN reduced NAD-capped RNAs.
n: not reported in source
Source sentences
We demonstrated that NMN supplementation increases NAD turnover coupled with a reduction in NAD-capped RNAs in both human and dog, revealing blood-derived NAD-RNAs as potential biomarkers sensitized to NMN exposure.
In dogs, NMN supplementation increased NAD turnover.
In plain wordsIn dogs, NMN increased NAD turnover.
dogn: not reported in source
Source sentences
We demonstrated that NMN supplementation increases NAD turnover coupled with a reduction in NAD-capped RNAs in both human and dog, revealing blood-derived NAD-RNAs as potential biomarkers sensitized to NMN exposure.
In dogs, NMN supplementation reduced NAD-capped RNAs.
In plain wordsIn dogs, NMN reduced NAD-capped RNAs.
dogn: not reported in source
Source sentences
We demonstrated that NMN supplementation increases NAD turnover coupled with a reduction in NAD-capped RNAs in both human and dog, revealing blood-derived NAD-RNAs as potential biomarkers sensitized to NMN exposure.
AI wrote and checked these results. AI can make mistakes, so check important results against the source.
PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.
Version 2Current
21 Oct 2026, 15:58 UTC
Study results updated
Version 1
21 Oct 2026, 12:50 UTC
First added · source update from Europe PMC
Terms as the source lists them.
PepBank is a research reference. Talk to a doctor before you use any peptide.
In PepBank now:147 peptides, 6 blends and 13 other compounds97,577 study results from 17,383 studies8,473 clinical trialsUpdated